79 related articles for article (PubMed ID: 1728407)
1. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels.
Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML
Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407
[TBL] [Abstract][Full Text] [Related]
2. Altered biodistribution of indium-111-labeled monoclonal antibody 96.5 to tumors and normal tissues of nude mice bearing human melanoma xenografts in visceral organs.
McCready DR; Price J; Balch CM; Murray JL
Cancer Immunol Immunother; 1989; 30(5):257-61. PubMed ID: 2624918
[TBL] [Abstract][Full Text] [Related]
3. Regression of human melanoma xenografts in nude mice injected with methotrexate linked to monoclonal antibody 225.28 to human high molecular weight-melanoma associated antigen.
Ghose T; Ferrone S; Blair AH; Kralovec Y; Temponi M; Singh M; Mammen M
Cancer Immunol Immunother; 1991; 34(2):90-6. PubMed ID: 1760821
[TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent difference in biodistribution of monoclonal antibodies in animal models and humans.
Oriuchi N; Watanabe N; Kanda H; Hashimoto M; Sugiyama S; Takenoshita S; Imai K; Ueda R; Endo K
Cancer Immunol Immunother; 1998 Aug; 46(6):311-7. PubMed ID: 9756415
[TBL] [Abstract][Full Text] [Related]
5. High-dose, unlabeled, nonspecific antibody pretreatment: influence on specific antibody localization to human melanoma xenografts.
Wahl RL; Wilson BS; Liebert M; Beierwaltes WH
Cancer Immunol Immunother; 1987; 24(3):221-4. PubMed ID: 3594484
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of chimeric anti-(ganglioside GD3) antibody KM871: antitumor activity in xenograft model of melanoma and effector function analysis.
Kanazawa J; Ohta S; Shitara K; Fujita F; Fujita M; Hanai N; Akinaga S; Okabe M
Cancer Immunol Immunother; 2000 Jul; 49(4-5):253-8. PubMed ID: 10941908
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and biodistribution of a new anti-episialin monoclonal antibody 139H2 in ovarian-cancer-bearing nude mice.
Molthoff CF; Pinedo HM; Schlüper HM; Boven E
Cancer Immunol Immunother; 1991; 34(3):191-7. PubMed ID: 1756536
[TBL] [Abstract][Full Text] [Related]
8. The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: an autoradiographic study.
Blumenthal RD; Fand I; Sharkey RM; Boerman OC; Kashi R; Goldenberg DM
Cancer Immunol Immunother; 1991; 33(6):351-8. PubMed ID: 1652355
[TBL] [Abstract][Full Text] [Related]
9. Criteria for selecting monoclonal antibodies with respect to accumulation in melanoma tissue.
Matzku S; Brüggen J; Bröcker EB; Sorg C
Cancer Immunol Immunother; 1987; 24(2):151-7. PubMed ID: 3829049
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody uptake in B-cell lymphomas: experimental studies in nude mouse xenografts.
Schmid J; Möller P; Moldenhauer G; Dörken B; Bihl H; Matzku S
Cancer Immunol Immunother; 1993; 36(4):274-80. PubMed ID: 7679951
[TBL] [Abstract][Full Text] [Related]
11. Tumor labeling in vivo using cyanine-conjugated monoclonal antibodies.
Ballou B; Fisher GW; Waggoner AS; Farkas DL; Reiland JM; Jaffe R; Mujumdar RB; Mujumdar SR; Hakala TR
Cancer Immunol Immunother; 1995 Oct; 41(4):257-63. PubMed ID: 7489569
[TBL] [Abstract][Full Text] [Related]
12. Detection of altered adhesion molecule expression in experimental tumors by a radiolabeled monoclonal antibody.
Saga T; Sakahara H; Yao Z; Nakamoto Y; Sato N; Hattori N; Zhang M; Zhao S; Aoki T; Miyatake S; Namba Y; Konishi J
Jpn J Cancer Res; 1997 Dec; 88(12):1171-80. PubMed ID: 9473735
[TBL] [Abstract][Full Text] [Related]
13. The role of monoclonal antibody A7 as a drug modifier in cancer therapy.
Kitamura K; Miyagaki T; Yamaoka N; Tsurumi H; Noguchi A; Yamaguchi T; Takahashi T
Cancer Immunol Immunother; 1993; 36(3):177-84. PubMed ID: 8439978
[TBL] [Abstract][Full Text] [Related]
14. Ab locks for improving the selectivity and safety of antibody drugs.
Lin WW; Lu YC; Chuang CH; Cheng TL
J Biomed Sci; 2020 Jun; 27(1):76. PubMed ID: 32586313
[TBL] [Abstract][Full Text] [Related]
15. Intravital Microscopy Reveals Unforeseen Biodistribution Within the Liver and Kidney Mechanistically Connected to the Clearance of a Bifunctional Antibody.
Datta-Mannan A; Molitoris BA; Feng Y; Martinez MM; Sandoval RM; Brown RM; Merkel D; Croy JE; Dunn KW
Drug Metab Dispos; 2023 Mar; 51(3):403-412. PubMed ID: 36460476
[TBL] [Abstract][Full Text] [Related]
16. Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance.
Thurber GM; Schmidt MM; Wittrup KD
Adv Drug Deliv Rev; 2008 Sep; 60(12):1421-34. PubMed ID: 18541331
[TBL] [Abstract][Full Text] [Related]
17. Physiological Considerations for Modeling
Dunlap T; Cao Y
Front Pharmacol; 2022; 13():856961. PubMed ID: 35281913
[TBL] [Abstract][Full Text] [Related]
18. Tissue Physiology of Cynomolgus Monkeys: Cross-Species Comparison and Implications for Translational Pharmacology.
Mandikian D; Figueroa I; Oldendorp A; Rafidi H; Ulufatu S; Schweiger MG; Couch JA; Dybdal N; Joseph SB; Prabhu S; Ferl GZ; Boswell CA
AAPS J; 2018 Oct; 20(6):107. PubMed ID: 30298434
[TBL] [Abstract][Full Text] [Related]
19. Quantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imaging.
Tichauer KM; Wang Y; Pogue BW; Liu JT
Phys Med Biol; 2015 Jul; 60(14):R239-69. PubMed ID: 26134619
[TBL] [Abstract][Full Text] [Related]
20. A mechanistic compartmental model for total antibody uptake in tumors.
Thurber GM; Dane Wittrup K
J Theor Biol; 2012 Dec; 314():57-68. PubMed ID: 22974563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
